Perceptions of influenza and pneumococcal vaccine uptake by older persons in Australia

Briggs, Lynne; Fronek, Patricia; Quinn, Val; Wilde, Tracy

doi:10.1016/j.vaccine.2019.06.079

Cited by 20 publications

(26 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the univariate analysis, older people with a lower educational level were more likely to participate in influenza vaccination campaigns compared to those with university studies. This finding is similar to that found in other studies [12,58]. Moreover, several studies conducted in European countries where the vaccination of elderly persons is provided free-of-charge found that educational level was not a major determinant of vaccination [49,59].…”

Section: Discussionsupporting

confidence: 91%

Trends, Coverage and Influencing Determinants of Influenza Vaccination in the Elderly: A Population-Based National Survey in Spain (2006–2017)

Cruz

Cebrino

2020

Vaccines

View full text Add to dashboard Cite

Influenza is a significant public health problem and the elderly are at a greater risk of contracting the disease. The vaccination coverage of the elderly is below the Spanish target of 65% for each influenza season. The aims of this study were to report the coverage of influenza vaccination in Spain among the population aged ≥65 years and high-risk groups for suffering chronic diseases, to analyze the time trends from 2006 to 2017 and to identify the factors which affect vaccination coverage. A nationwide cross-sectional study was conducted including 20,753 non-institutionalized individuals aged ≥65 years who had participated in the Spanish National Health Surveys in 2006, 2011/2012, and 2017. Sociodemographic, health-related variables, and influenza vaccination data were used. A logistic regression analysis was performed to determine the variables associated with influenza vaccination. Influenza vaccination coverage was 60%. By chronic condition, older people with high cholesterol levels and cancer had the lowest vaccination coverage (62.41% and 60.73%, respectively). This coverage declined from 2006 to 2017 in both groups. Higher influenza vaccination was associated with males, Spanish nationality, normal social support perceived, polypharmacy, worse perceived health, participation in other preventive measures, and increasing age and the number of chronic diseases.

show abstract

Section: Discussionsupporting

confidence: 91%

Trends, Coverage and Influencing Determinants of Influenza Vaccination in the Elderly: A Population-Based National Survey in Spain (2006–2017)

Cruz

Cebrino

2020

Vaccines

View full text Add to dashboard Cite

show abstract

“…The findings suggests that, to increase vaccine coverage in older adults, targeted public health action is required, which is to some extent tailored to the requirements of the specific vaccines (Klett-Tammen et al 2016). Sense of social responsibility and concern for others' health (collective responsibility) was found to be an important factor in general vaccine uptake in this population (Briggs et al, 2019). Therefore, public health messaging could usefully highlight the societal benefits of good vaccine coverage.…”

Section: Discussionmentioning

confidence: 94%

“…Also, given the importance of receiving a healthcare provider's recommendation to vaccinate (e.g. Briggs et al, 2019), enhancing healthcare providers' knowledge regarding specific vaccination effectiveness could potentially increase recommendations to vaccinate (Ehresmann et al, 2001;Santibanez et al, 2002;Schneeberg et al, 2014). For example, a recent intervention focusing on increasing awareness and knowledge via primary healthcare (i.e.…”

Section: Discussionmentioning

confidence: 99%

“…Yet, despite the established benefits, and although vaccination coverage varies by country, influenza vaccination coverage almost always falls short of the World Health Organization's (WHO's) target of 75% of older adults (WHO Regional Office for Europe, 2014;Dios-Guerra et al, 2017). Pneumococcal vaccination uptake is around 51-69% in older adults, depending on which country is examined (Briggs et al, 2019;Gatwood et al, 2020), and shingles uptake rates can be lower than 50% in some eligible cohorts (Public Health England, 2020).…”

Section: Highlightsmentioning

confidence: 99%

See 1 more Smart Citation

Older adults' vaccine hesitancy: psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.

Nicholls¹,

Gallant²,

Cogan³

et al. 2020

Preprint

View full text Add to dashboard Cite

Influenza, pneumococcal disease, and shingles (herpes zoster) are more prevalent in older people. These illnesses are preventable via vaccination, but uptake is low and decreasing. Little research has focused on understanding the psychosocial reasons behind older adults’ hesitancy towards different vaccines. A cross-sectional survey with 372 UK-based adults aged 65-92 years (M = 70.5) assessed awareness and uptake of the influenza, pneumococcal, and shingles vaccines. Participants provided health and socio-demographic data and completed two scales measuring the psychosocial factors associated with vaccination behaviour. Self-reported daily functioning, cognitive difficulties, and social support were also assessed. Participants were additionally given the opportunity to provide free text responses outlining up to three main reasons for their vaccination decisions. We found that considerably more participants had received the influenza vaccine in the last 12 months (83.6%), relative to having ever received the pneumococcal (60.2%) and shingles vaccines (58.9%). Participants were more aware of their eligibility for the influenza vaccine, and were more likely to have been offered it. Multivariate logistic regression analyses showed that a lower sense of collective responsibility independently predicted lack of uptake of all three vaccines. Greater calculation of disease and vaccination risk, and preference for natural immunity, also predicted not getting the influenza vaccine. For both the pneumococcal and shingles vaccines, concerns about profiteering further predicted lack of uptake. Analysis of the qualitative responses highlighted that participants vaccinated to protect their own health and that of others. Our findings suggest that interventions targeted towards older adults would benefit from being vaccine-specific and that they should emphasise disease risks and vaccine benefits for the individual, as well as the benefits of vaccination for the wider community. These findings can help inform intervention development aimed at increasing vaccination uptake in future.

show abstract

“…Second, awareness of the pneumococcal vaccination recommendation is probably lower among both physicians and patients than for influenza vaccine [ 26 ]. Seasonal influenza vaccination is well publicized across all age groups promoted by campaigns and health professionals and in workplaces, whereas pneumococcal vaccination appears to have a much lower promotion [ 27 ]. Patients aged 65 years and older receive a voucher from the French national health insurance to be vaccinated against influenza, whereas this is not the case for pneumococcus vaccine.…”

Section: Discussionmentioning

confidence: 99%

Effectiveness of a Multifaceted Informational-Based and Text Message Reminders on Pneumococcal and Influenza Vaccinations in Hospital Emergency Departments: A Cluster-Randomized Controlled Trial

et al. 2021

View full text Add to dashboard Cite

Objectives. We aimed to evaluate the effectiveness of a multifaceted procedure in improving pneumococcal and influenza vaccinations 6 months after an emergency department (ED) visit among patients aged 65 years and older. Methods. We conducted a cluster-randomized, controlled, parallel-group, open-label implementation trial in 18 EDs in France and Monaco. Participants were recruited from November 2015 to September 2016. EDs were randomly assigned with a 1:1 ratio to provide either a multifaceted procedure that combined structured information about pneumococcal and influenza vaccines and three text message reminders sent to patients every two weeks (intervention arm) or nonstructured information only (control arm). The outcomes were self-reported pneumococcal vaccination and influenza vaccination rates within 6 months of enrollment. Results. A total of 9 EDs were randomized to the intervention arm (n = 780 patients) and 9 to the control arm (n = 695 patients). The median age for all enrolled patients was 74 years (25–75th percentiles, 69 to 82): 50.1% were male, 34.9% had at least one underlying condition, and 30.7% were at risk for invasive pneumococcal infection. In the intention-to-treat analysis, the multifaceted intervention did not alter the pneumococcal vaccination rate (6.4% versus 4.6%, absolute difference: 1.8; 95% CI: [−0.9 to 4.4]; p = 0.19), whereas it improved the influenza vaccination rate (52.1% versus 40.0%, absolute difference: 12.1; 95% CI: [2.4 to 21.8]; p = 0.01). At 12 months, mortality did not differ between the intervention (9.7%) and control (11.2%) arms (p = 0.35). Conclusions. A multifaceted intervention based on text message reminders provides an opportunity to increase anti-influenza vaccination among elderly patients visiting the ED. Efforts are warranted to provide better information on pneumococcal diseases and the benefits of pneumococcal vaccines, especially in the elderly.

show abstract

Perceptions of influenza and pneumococcal vaccine uptake by older persons in Australia

Cited by 20 publications

References 29 publications

Trends, Coverage and Influencing Determinants of Influenza Vaccination in the Elderly: A Population-Based National Survey in Spain (2006–2017)

Trends, Coverage and Influencing Determinants of Influenza Vaccination in the Elderly: A Population-Based National Survey in Spain (2006–2017)

Older adults' vaccine hesitancy: psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.

Effectiveness of a Multifaceted Informational-Based and Text Message Reminders on Pneumococcal and Influenza Vaccinations in Hospital Emergency Departments: A Cluster-Randomized Controlled Trial

Contact Info

Product

Resources

About